Market access strategies
Strategic insights and research
Value demonstration
Value communication
Commercialization support and vendor management
Case studies
Thought leadership


As fully integrated pharmaceutical companies rapidly shift priorities internally to better support the development and commercialization of expensive therapies for chronic and terminal illnesses over the coming decade, demonstrating economic value to payers globally is of increasing importance.  Understanding how payers think, and developing projections of potential reactions to various sets of clinical and economic data well in advance of program implementation, is absolutely critical to our client’s financial growth and stability.